Management of tegmen defects with mastoid and epitympanic obliteration using S53P4 bioactive glass
Management of tegmen defects with mastoid and epitympanic obliteration using S53P4 bioactive glass
About this item
Full title
Author / Creator
Publisher
Hoboken, USA: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Hoboken, USA: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Objective
To evaluate the surgical results and complications in a cohort of patients operated on to repair a tegmen bony defect using either transmastoid approach with obliteration using S53P4 bioactive glass granules (TMA‐O), or the classic middle cranial fossa approach (MCFA).
Study design
A retrospective monocentric study.
Methods
Alternative Titles
Full title
Management of tegmen defects with mastoid and epitympanic obliteration using S53P4 bioactive glass
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_009a541ae584409fb4388b48e65dbda4
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_009a541ae584409fb4388b48e65dbda4
Other Identifiers
ISSN
2378-8038
E-ISSN
2378-8038
DOI
10.1002/lio2.374
